Nag-aapply na para makapagsagawa ng clinical trials sa bansa ang tatlong developer ng coronavirus disease 2019 (COVID-19) vaccines.
Kabilang dito, ayon kay Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevarra, ang West China Hospital and Sichuan University, Shenzhen Kangtao Biological Products Company at Eubiologics Company Limited.
Sinabi ni Guevarra na sinimulan nang pag-aralan ng Task Group on Vaccine Evaluation and Selection ang clinical trial applications ng mga nasabing vaccine developers.
Una nang inaprubahan ng Food and Drug Administration ang clinical trials ng COVID-19 vaccine manufacturers na Janssen, Clover Biopharmaceuticals at Sinovac Biotech.
